US And EU Regulatory Submissions For Vandetanib In Advanced Medullary Thyroid...
AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib...
View ArticleNew First-line Therapy Now Available For Treatment Of Advanced Hormone...
TykerbTM (lapatinib ditosylate) has received Health Canada approval for use in combination with letrozole (an aromatase inhibitor) for the treatment of post-menopausal women with hormone...
View Article
More Pages to Explore .....
